Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Feelders

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Nederlands Tijdschrift Voor Tandheelkunde|February 11, 2004
[Acromegaly. Treatment of the causal factor and the oral sequelae]R A Feelders, E J Delwel, C de Baat
Pituitary|March 1, 2015
Comorbidities in Cushing's diseaseS T Sharma, L K Nieman, R A Feelders
Nederlands Tijdschrift Voor Geneeskunde|August 5, 2004
[Posttraumatic hypopituitarism]R A Alwani, R A Feelders, S W J Lamberts
Endocrinology|July 26, 2011
Selective glucocorticoid receptor modulators: future of glucocorticoid immunosuppressive therapy?R A M Quax, R P Peeters, R A Feelders
Clinical Chemistry and Laboratory Medicine|March 27, 1999
Structure, function and clinical significance of transferrin receptorsR A Feelders, E P Kuiper-Kramer, H G van Eijk
Nederlands Tijdschrift Voor Geneeskunde|March 22, 2007
[Cushing's syndrome in children]M O van Aken, R A Feelders, W W de Herder
European Journal of Endocrinology|June 26, 2012
The burden of Cushing's disease: clinical and health-related quality of life aspectsR A Feelders, S J Pulgar, A Kempel, et al.
Acta Haematologica|January 1, 1993
Iron chelators may enhance erythropoiesis by increasing iron delivery to haematopoietic tissue and erythropoietin response in iron-loading anaemiaG Vreugdenhil, M Smeets, R A Feelders, et al.
Nephron|January 1, 1992
Possible mechanisms underlying potentiating effects of iron chelators in hematopoietic response to erythropoietinG Vreugdenhil, R A Feelders, P J Coppens, et al.
The Netherlands Journal of Medicine|April 19, 2018
A rare cause of dysregulated metabolic syndrome: cortisol-producing adrenocortical carcinomaL Saes, I A Boere, J Hofland, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Nederlands Tijdschrift Voor Tandheelkunde|February 11, 2004
[Acromegaly. Treatment of the causal factor and the oral sequelae]R A Feelders, E J Delwel, C de Baat
Pituitary|March 1, 2015
Comorbidities in Cushing's diseaseS T Sharma, L K Nieman, R A Feelders
Nederlands Tijdschrift Voor Geneeskunde|August 5, 2004
[Posttraumatic hypopituitarism]R A Alwani, R A Feelders, S W J Lamberts
Endocrinology|July 26, 2011
Selective glucocorticoid receptor modulators: future of glucocorticoid immunosuppressive therapy?R A M Quax, R P Peeters, R A Feelders
Clinical Chemistry and Laboratory Medicine|March 27, 1999
Structure, function and clinical significance of transferrin receptorsR A Feelders, E P Kuiper-Kramer, H G van Eijk
Nederlands Tijdschrift Voor Geneeskunde|March 22, 2007
[Cushing's syndrome in children]M O van Aken, R A Feelders, W W de Herder
European Journal of Endocrinology|June 26, 2012
The burden of Cushing's disease: clinical and health-related quality of life aspectsR A Feelders, S J Pulgar, A Kempel, et al.
Acta Haematologica|January 1, 1993
Iron chelators may enhance erythropoiesis by increasing iron delivery to haematopoietic tissue and erythropoietin response in iron-loading anaemiaG Vreugdenhil, M Smeets, R A Feelders, et al.
Nephron|January 1, 1992
Possible mechanisms underlying potentiating effects of iron chelators in hematopoietic response to erythropoietinG Vreugdenhil, R A Feelders, P J Coppens, et al.
The Netherlands Journal of Medicine|April 19, 2018
A rare cause of dysregulated metabolic syndrome: cortisol-producing adrenocortical carcinomaL Saes, I A Boere, J Hofland, et al.
Pageof 8